Susan D. Demo - Concepedia

Author

Susan D. Demo

Calithera (United States)

Also Known As

Jean Emmanuel Sarry, S D Demo, S Demo, S. Demo, S.D. Demo, Susan D Demo, Susan D. Demo, Susan Demo, Susan D. Demo

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Calithera (United States)Rigel (United States)Stanford University Howard Hughes Medical Institute The University of Texas MD Anderson Cancer Center

About

Susan D. Demo is an author at Calithera (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.1K
2	Natural Sciences	4	4	422
3	Biochemistry	4	4	1.2K
4	Cell Biology	3	3	784
5	Social Sciences	1	1	45

Susan D. Demo

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer Matt I. Gross, Susan D. Demo, Jennifer B. Dennison, Molecular Cancer Therapeutics Glutamine ConsumptionBreast OncologyAntitumor ActivityPathologyTumor Biology	2014	1K
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma Deborah J. Kuhn, Qing Chen, Peter M. Voorhees, Blood	2007	762
Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome Susan D. Demo, Christopher J. Kirk, Monette Aujay, Cancer Research	2007	668
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis Tony Muchamuel, Michael Basler, Monette Aujay, Nature Medicine InflammationRheumatologyCytokineRheumatoid DisorderAutoimmune Disease	2009	590
The inactivation gate of the Shaker K+ channel behaves like an open-channel blocker Susan D. Demo, Gary Yellen Neuron	1991	313
Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047) Han-Jie Zhou, Monette Aujay, Mark K. Bennett, Journal of Medicinal Chemistry	2009	271
ralGDS family members interact with the effector loop of ras p21. Akira Kikuchi, Susan D. Demo, Z H Ye, Molecular and Cellular Biology Protein FunctionSignal TransductionProtein AssemblyNeurofibromatosis Gene ProductNatural Sciences	1994	257
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma Milica Momcilovic, Sean T. Bailey, Jason T. Lee, Cancer Cell Tumor BiologyMedicineCancer BiologyTumor SuppressorRadiation Oncology	2018	178
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer Milica Momcilovic, Sean T. Bailey, Jason T. Lee, Cell Reports	2017	162
Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay Susan D. Demo, Esteban S. Masuda, Alexander B. Rossi, Cytometry	1999	127

Page 1